Reata Pharmaceuticals, Inc.
RETA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$311,901 | -$297,386 | -$247,752 | -$290,170 |
| Dep. & Amort. | $1,130 | $1,203 | $1,136 | $932 |
| Deferred Tax | $0 | $0 | $11,183 | $0 |
| Stock-Based Comp. | $58,731 | $56,806 | $57,633 | $26,381 |
| Change in WC | $9,309 | -$49,575 | -$172,683 | $10,332 |
| Other Non-Cash | $38,464 | $53,251 | $28,143 | $1,374 |
| Operating Cash Flow | -$204,267 | -$235,701 | -$322,340 | -$251,151 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,270 | -$1,329 | -$927 | -$2,673 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$661,894 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $320,000 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$345,164 | -$1,329 | -$927 | -$2,673 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $333,278 | $333,278 | $492,453 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,485 | $9,138 | $477,093 | $580,358 |
| Financing Cash Flow | $1,485 | $9,138 | $477,093 | $580,358 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$547,946 | -$227,892 | $153,826 | $326,534 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $590,258 | $818,150 | $664,324 | $337,790 |
| End Cash | $42,312 | $590,258 | $818,150 | $664,324 |
| Free Cash Flow | -$207,537 | -$237,030 | -$323,267 | -$253,824 |